S. 1095
March 24, 2025
Ms. Klobuchar (for herself, Mr. Grassley, Mr. Durbin, Mr. Blumenthal, Mr. Cruz, Mr. Welch, and Mr. Booker) introduced the following bill; which was read twice and referred to the Committee on the Judiciary
A BILL
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act” or the “Stop STALLING Act”.